Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis

Joseph K. Rathkey(University School), Junjie Zhao(Cleveland Clinic Lerner College of Medicine), Zhonghua Liu(University School), Yinghua Chen(University School), Jie Yang(University School), Hannah Kondolf(University School), Bryan L. Benson(University School), Steven M. Chirieleison(University School), Alex Y. Huang(University School), George Dubyak(University School), Tsan Sam Xiao(University School), Xiaoxia Li(Cleveland Clinic Lerner College of Medicine), Derek W. Abbott(University School)
Science Immunology
August 3, 2018
Cited by 589Open Access
Full Text

Abstract

Dysregulation of inflammatory cell death is a key driver of many inflammatory diseases. Pyroptosis, a highly inflammatory form of cell death, uses intracellularly generated pores to disrupt electrolyte homeostasis and execute cell death. Gasdermin D, the pore-forming effector protein of pyroptosis, coordinates membrane lysis and the release of highly inflammatory molecules, such as interleukin-1β, which potentiate the overactivation of the innate immune response. However, to date, there is no pharmacologic mechanism to disrupt pyroptosis. Here, we identify necrosulfonamide as a direct chemical inhibitor of gasdermin D, the pyroptotic pore-forming protein, which binds directly to gasdermin D to inhibit pyroptosis. Pharmacologic inhibition of pyroptotic cell death by necrosulfonamide is efficacious in sepsis models and suggests that gasdermin D inhibitors may be efficacious clinically in inflammatory diseases.


Related Papers

No related papers found

Powered by citation graph analysis